Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Affimed Ord Shs
(NQ:
AFMD
)
4.210
+0.080 (+1.94%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Affimed Ord Shs
< Previous
1
2
3
Next >
Affimed Reports Third Quarter 2022 Financial Results and Highlights Recent Clinical and Corporate Progress
November 15, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed Provides Data Update from Two Phase 1/2a Trials with its Innate Cell Engager AFM24 in Solid Tumor Patients at the 37th SITC Annual Meeting
November 07, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed to Report Third Quarter 2022 Financial Results & Corporate Update on November 15, 2022
November 04, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101
November 03, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting
November 03, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed to Present at the 2022 Jefferies London Healthcare Conference
November 01, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed Announces Two Clinical Update Presentations on its Novel Bispecific Innate Cell Engager AFM24 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 05, 2022
From
Affimed N.V.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.